Profound Medical
PROF
57 hedge funds and large institutions have $106M invested in Profound Medical in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 16 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.38% less ownership
Funds ownership: 45.4% → 45.02% (-0.38%)
10% less funds holding
Funds holding: 63 → 57 (-6)
16% less capital invested
Capital invested by funds: $126M → $106M (-$20.7M)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
70% less call options, than puts
Call options by funds: $140K | Put options by funds: $467K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$3.05M |
| 2 |
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Dallas,
Texas
|
+$1.91M |
| 3 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$1.48M |
| 4 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$1.14M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$967K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.34M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.44M |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$1.66M |
| 4 |
EAM
Empery Asset Management
New York
|
-$1.13M |
| 5 |
ZDA
Zweig-DiMenna Associates
New York
|
-$1.02M |
PROF Hedge Fund Activity: Q1 2026 in Review
57 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q1 2026, worth a combined $106M — down 16% from $126M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PROF and 10 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 21 added.
The largest buyer was Lagoda Investment Management, opening a new position worth an estimated $3.05M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $5.34M sold.
- 57 institutional investors held Profound Medical (PROF) as of Q1 2026, down from 63 in Q4 2025.
- Funds reported $106M of Profound Medical stock for Q1 2026, down 16% quarter-over-quarter.
- 10 funds opened new Profound Medical positions in Q1 2026 and 16 closed out, a net change of -6 holders.
- The largest Profound Medical buyer in Q1 2026 was Lagoda Investment Management, an estimated $3.05M added.
- The largest Profound Medical seller in Q1 2026 was Alyeska Investment Group, an estimated $5.34M sold.
Based on aggregated 13F filings for Q1 2026.